Boule Diagnostics
3.44 SEK
-4.71 %
Less than 1K followers
BOUL
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Boule Diagnostics
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 48.29 | 42.13 | 34.56 | 15.10 | 11.22 | 8.98 | 4.91 |
| Shares | 27.3 | 27.4 | 27.4 | 38.8 | 38.8 | 38.8 | 38.8 |
| Market cap | 1,319.8 | 1,155.3 | 947.5 | 586.4 | 435.7 | 348.7 | 190.7 |
| Enterprise value | 1,327.1 | 1,160.0 | 948.2 | 679.5 | 564.5 | 521.0 | - |
| EV/S | 2.7 | 2.9 | 2.0 | 1.2 | 1.0 | 0.9 | - |
| EV/EBITDA | 19.0 | neg. | 26.3 | 23.4 | 14.4 | neg. | - |
| EV/EBIT | 19.0 | neg. | 26.3 | 23.4 | 14.4 | neg. | - |
| P/E | 35.2 | neg. | 40.7 | 32.8 | 17.5 | neg. | neg. |
| P/B | 3.96 | 4.29 | 3.20 | 1.27 | 0.92 | 1.29 | 1.14 |
| P/S | 2.6 | 2.9 | 2.0 | 1.1 | 0.8 | 0.6 | 0.4 |
| Dividend yield | 0.0 % | 0.9 % | 1.1 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 56.7 % | 56.1 % | 51.7 % | 60.9 % | 62.9 % | 45.7 % | 35.7 % |
| Gearing ratio | 46.1 % | 46.6 % | 52.6 % | 41.1 % | 35.0 % | 72.3 % | 129.1 % |